
Hiep C. Nguyen
@drnguyenhiep
Research Fellow
Dana-Farber Cancer Institute - Harvard Medical School
MD, PhD, Pathologist
ID: 3229924758
29-05-2015 17:24:31
398 Tweet
1,1K Followers
4,4K Following






Good CAF or bad CAF, that's the question! In our new paper Cancer Cell we use #imagingmasscytometry to unravel the prognostic effect of cancer-associated #fibroblast (CAF) heterogeneity&their effect on therapy in 1000+ Unispital_USZ lung cancer patients cell.com/cancer-cell/fu…




Happening now 9AM- 12:30PM! “Dissecting acquired resistance to KRASG12D inhibition in a mouse model of pancreatic ductal adenocarcinoma” #AACR2024 authored by our TeamLab members Julien Dilly, Shalek Lab, S. Chugh,S. Dougan, B. Wolpin, Jonathan A. Nowak, Peter Winter, A. Aguirre


It's out! We report 3D mapping of human pancreatic precancer and associated genetic alterations. With the brilliant Ashley Kiemen and Denis Wirtz . Tweetorial to follow soon. nature.com/articles/s4158…


We are delighted to celebrate Dr. Laurie Glimcher Laurie Glimcher MD , a valued member of our board, for her remarkable tenure as President and CEO, now President Emerita, of Dana-Farber. We also look forward to continued collaboration under the new leadership of Dr. Benjamin Ebert, a



New nature research paper: A pathology foundation model for cancer diagnosis and prognosis prediction. Kun-Hsing Yu Nancy Lin, MD Eliana Marostica Lynette Sholl David Meredith Shuji Ogino pubmed.ncbi.nlm.nih.gov/39232164/




Sharing Andrew Bellizzi 🇺🇦 wallhangers Hans Popper Hepatopathology Society USCAP These are gold!!!

